ZAGREB, June 10 (Hina) - Croatia's pharmaceutical firm 'Pliva', has
finished the construction of a new plant for 'azitromicin'. The plant,
built at Savski Marof, near Zagreb, was worth 150 million German marks,
its director Zeljko Brebric said.
The plant will produce 80 tonnes of azitromicin next year, whereas
by 2000 the yearly production will come to 100 tonnes, and later on to
200 tonnes.
This antibiotic, found 20 years ago at Pliva research laboratory,
has been produced by the Croatian firm since 1982. Between 60 and 70
tonnes are produced every year, and most of this amount is taken by a
U.S. firm, 'Pfizer', that sells it on the world market under the name
'Zitromax'. The rest is sold on the Croatian market under the name
'Sumamed'.
(hina) mm mš
101410 MET jun 97
Duran Duran će nakon 40 godina opet nastupiti na Sanremu
DOPUNA VIJESTI: Lokalni izbori: U bitku za Zagreb i ovaj put dvoznamenkasti broj...
U zasjedi Udineseovih navijača ozlijeđeno najmanje šest osoba
Grčka upozorila na pojačanu seizmičku aktivnost na Santoriniju
Sljedeći tjedan u Europskoj uniji
Britanski kralj Karlo producirat će dokumentarac o 'filozofiji harmonije'
Čelnici EU-a na neformalnom skupu o jačanju obrambenih sposobnosti
Kanada, Meksiko i Kina uzvraćaju protumjerama na američke carine
NBA: Pobjeda Denvera, Washington prekinuo niz od 16 poraza
SKV: Svijet u 9,30 sati